United States ex rel. Franklin v. Parke-Davis

210 F.R.D. 257, 2002 U.S. Dist. LEXIS 19910, 2002 WL 31356361
CourtDistrict Court, D. Massachusetts
DecidedOctober 10, 2002
DocketNo. 96-CV-11651-PBS
StatusPublished
Cited by4 cases

This text of 210 F.R.D. 257 (United States ex rel. Franklin v. Parke-Davis) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States ex rel. Franklin v. Parke-Davis, 210 F.R.D. 257, 2002 U.S. Dist. LEXIS 19910, 2002 WL 31356361 (D. Mass. 2002).

Opinion

MEMORANDUM AND ORDER

SARIS, District Judge.

INTRODUCTION

This is a qui tam action pursuant to 31 U.S.C. §§ 3729-33 alleging that defendant Parke-Davis made various false Medicaid claims in connection with the marketing and sale of its drug Neurontin.1 The New York Times Company, the publisher of the New York Times and the Boston Globe, and the National Broadcasting Company, Inc. (the “media entities”) seek to intervene to modify a protective order that defendant Parke-Davis claims bars Relator, plaintiff Dr. David Franklin, from distributing non-privileged documents produced in discovery to the press.2 The media entities contend that the [258]*258protective order is overbroad and violates the First Amendment.3 Parke-Davis claims that release of the documents would jeopardize its right to a fair trial and that modification of the protective order is unjustified. The Relator supports the position of the media entities, indicating that he will release non-privileged documents if the protective order is modified. After hearing, the motion is ALLOWED.

DISCUSSION

1. Intervention

Third parties, like the media entities, “have standing to assert their claim of access to documents in a judicial proceeding.” See Public Citizen v. Liggett Group, Inc., 858 F.2d 775, 787 (1st Cir.1988) (“Public Citizen”) (involving a protective order barring the nonlitigatory use of all future discovery in tobacco litigation). The proper procedural method for asserting access to discovery materials subject to a protective order is a motion to intervene pursuant to Fed.R.Civ.P. 24. See id. at 783. Because the protective order was entered in January 2002, and discovery is ongoing, the motion is timely. Both as a matter of discretion and of right, I ALLOW the motion to intervene.

2. The Motion

The intervenors ask the Court to clarify or modify the protective order to allow parties to disseminate non-confidential discovery material. Courts have the inherent power to modify protective orders in light of changed circumstances during the time that such orders are in effect. Id. at 782. See the Manual for Complex Litigation (Third) § 21.432 (1995) (“A protective order is always subject to modification or termination for good cause. Even where the parties have consented to the protective order ... non parties, including the media ... may seek modification to allow access to protected information.”).

The Protective Order states, in relevant part:

1. This Order shall govern the treatment of pleadings, correspondence, legal memo-randa, documents (as defined by the Federal Rules of Civil Procedure and the Local Rules) and all other discovery materials which have been or will be filed, exchanged, served, produced or received by the parties during pre-trial proceedings in the above-captioned action, as well as any and all copies, abstracts and summaries (the “Discovery Materials”). Any person, other than the producing party, who shall obtain access to Discovery Materials shall use such Discovery Materials only in connection with the prosecution or defense of the above-captioned action and for no other purpose whatsoever.
2. (a) All documents and information furnished by a party in conjunction with this litigation which contain or disclose trade secrets or other confidential research, development, or commercial information (“Confidential Information”) may be designated CONFIDENTIAL by said party and furnished to the other parties pursuant to the terms of this Order. The party receiving designated Confidential Information shall treat it as proprietary information and shall not use or disclose the information except for the purposes set forth in this Order or such orders as may be issued by the Court during the course of this litigation. The provisions of this Order extend to all designated Confidential Information regardless of the manner in which it is disclosed, including but not limited to documents, interrogatory answers, responses to requests for admissions, deposition transcripts, deposition exhibits, and any other discovery materials produced by a party in response to or in connection with any discovery conducted in this litigation, and any copies, notes, abstracts or summaries of the foregoing materials.
(b) A party may not designate as “Confidential” information contained in documents which are already in the possession of a third party even if the documents [259]*259contain the party’s “Confidential” information.
(c) The designation of information as “Confidential” shall constitute a representation that such document, material or information has been reviewed and that there is a good faith basis for such designation.....
4. Any confidential information received by a party shall be used by that party solely for the purpose of conducting this litigation ... and shall in no event be used for any business, competitive, personal, private, public, or other purpose, except as required by law.

The defendants interpret the first paragraph of the order to forbid the dissemination of any discovery material, even documents which are not confidential, to third-parties except in. connection with the prosecution or defense of the action. Disagreeing, intervenors point out that if the first paragraph is read to have this sweeping interpretation then paragraph four of the order is superfluous, since the provision governing the use of confidential material “solely for the purpose of conducting this litigation” would already be covered by the proscription against using any material for any purpose except the litigation. The Relator points out that he never understood the paragraph to apply to non-confidential materials.

While the proposed protective order was hotly contested in other respects before the magistrate judge and me, the first paragraph was not the crux of the earlier disputes because it was not objected to. Therefore, I did not address or focus on this paragraph in my earlier ruling on the scope of the protective order.

An analysis of the protective order as a whole suggests that defendants have the better argument regarding its scope, in light of the plain language of the first paragraph. Because the paragraph applies to all “Discovery Materials,” not just information designated confidential in Paragraph 2, defendants are correct that the protective order, as presently worded, bars nonlitigatory use of all materials provided during discovery. Paragraph 4 provides heightened protection for confidential materials, i.e., a requirement that any person shown confidential materials must sign an agreement. That interpretation refines the question before the Court: (1) Is such a broadly sweeping order lawful under Fed.R.Civ.P. 26

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Bulger
283 F.R.D. 46 (D. Massachusetts, 2012)
In Re Neurontin Marketing & Sales Practices Litigation
748 F. Supp. 2d 34 (D. Massachusetts, 2010)
Massachusetts v. Mylan Laboratories, Inc.
246 F.R.D. 87 (D. Massachusetts, 2007)
Marshall v. Planz
347 F. Supp. 2d 1198 (M.D. Alabama, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
210 F.R.D. 257, 2002 U.S. Dist. LEXIS 19910, 2002 WL 31356361, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-franklin-v-parke-davis-mad-2002.